Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis

Guidelines for treatment of metastatic pancreatic cancer recommend a second line based on Fluoropyrimidine (FP) alone or in combination with Oxaliplatin (OXA) or Irinotecan (IRI) after a first line treatment based on Gemcitabine (GEM). We conducted a Bayesian network meta-analysis to compare current...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Citterio, Chiara, Baccini, Michela, Orlandi, Elena, Di Nunzio, Camilla, Cavanna, Luigi
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Meta-Analysis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6049864/
https://ncbi.nlm.nih.gov/pubmed/30038721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25639
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados